Good morning!
You know it as Monsanto's Roundup. And it correlates closely with the explosion in breast and prostate cancers, among others.
Here is just one of many stunning graphs.
What's glyphosate? It's is the active ingredient in Roundup.
Monsanto's patent expired in 2000, and now the whole world makes it.
It is the world's most popular herbicide (weed-killer).
At one time, it was considered quite safe.
But, a growing body of research ties Roundup (glyphosate) to breast and other cancers, including prostate:
Glyphosate induces human breast cancer cells growth via estrogen receptors.
Glyphosate-based herbicides are toxic and endocrine disruptors in human cell lines.
Glyphosate, pathways to modern diseases IV: cancer and related pathologies.
What can we do about it?
People are spending thousands of dollars on expensive filtration systems that may get it all out. But not everyone has that kind of money.
Our technology is different. We use electricity. It is highly efficient.
For this and many other contaminants in our fresh water, we believe that ours is the technology of the future.
An ambitious program
We have launched a far-reaching program to complete the testing, finalize the process, and get it into the market through partners.
A very exciting part of the program may include sophisticated gene testing on lab animals.
By helping us fund this million-dollar effort, you can help make this program a reality.
It doesn't take much — the minimum is just $10,000*.
Yes, you could win as a shareholder.
Even more important, you could help bring a technology to market that could really make a difference in longer and healthier lives.
If you're an accredited investor, reply to this email and I will quickly get you the information you need.
Our own research database.
I will also give you early access to our microtoxin database. You will be shocked and amazed at what is in our water, I'm sure.
Reply now. You're a vital contributor to this effort.
Have a great week!
Riggs and Team
Riggs Eckelberry
President & CEO
OriginClear, Inc. (OCLN)
